Judge Rules ReWalk Device Is Medically Necessary for Medicare
Medicare exoskeleton coverage approved for ReWalk Personal Exoskeleton, sets key precedent.
Read MorePosted by Shajini | Jun 27, 2025 | Litigation, Law & Policy, Neurology, News, Pricing & Market Access
Medicare exoskeleton coverage approved for ReWalk Personal Exoskeleton, sets key precedent.
Read MorePosted by Shajini | Jun 9, 2025 | Cardiometabolic, Litigation, Law & Policy, MedTech, News
J&J’s $147M antitrust penalty tripled to $442M for monopolizing cardiac catheter market.
Read More